Home Tags Cannabis

Cannabis Related Content

use of medical cannabis

The use of medical cannabis in the UK

Andreas Met, COO, Compliance and Director at Halo Labs highlights how the use of medical cannabis is on the rise in the UK and could offer relief to many NHS patients.
medical marijuana

A medical professional’s opinion on medical marijuana

Dr Charlie Easmon from Your Excellent Health Service gives a medical professional’s opinion on medical marijuana in the UK, including comment on hemp, CBD and THC.
priorities for cannabis research

The priorities for cannabis research

Here, Robin Emerson, Head of CSR at Brains Bioceutical charts the priorities for cannabis research.
UK’s clinicians

The UK’s clinicians need training in medical cannabis – here’s why

Professor Mike Barnes, Co-Founder of Maple Tree Consultancy states that the UK’s clinicians need training in medical cannabis and explains precisely why this should be.
post-covid-19 economy

Can the UK’s post-COVID-19 economy benefit from a booming medical cannabis industry?

Hannah Deacon, Co-Founder of Maple Tree Consultancy and Campaigner ponders if the UK’s post-COVID-19 economy can benefit from a booming medical cannabis industry.
OCD symptoms, CBD

Research finds cannabis could reduce OCD symptoms by 50%

OCD symptoms could be eased by atleast half in the short-term, according to a new study published in the Journal of Affective Disorders.
CBG

CBG: The mother of all Cannabinoids with broad antibacterial activity

Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains CBG (cannabigerol), a “new” cannabinoid with vast potential in cannabis research.
savage cabbage

Savage Cabbage: Where did it begin?

In early 2016, I had reached a point in life where I needed to make a life-changing decision: Read the Savage Cabbage journey on OAG.
EUMCA, Brexit

EUMCA: Medical cannabis and research collaboration after Brexit

Here, we talk to Professor Trevor Jones at the European Medical Cannabis Association (EUMCA) about storing CBD, clinical trials post-Brexit and the UK-US trade deal.
narcotic

CBD: Narcotic substance or a novel food product?

CBD is at the forefront of pharmacology. So why has the European Commission changed its recommended status to “Narcotic”? Read on to find out more.
medical application of CBD, covid

COVID is shifting the conversation about the medical application of CBD

Hannah Deacon, co-founder of Maple Tree Consultancy, explores how COVID is elevating and shaping the medical application of CBD.
CBD in the UK, dose

A comprehensive guide to CBD in the UK

Here, Professor Mike Barnes discusses and answers some key questions about the world of CBD in the UK.
Quality of medicinal cannabis, purely plant

Ensuring a high and reproducible quality of medicinal cannabis

Renata Mala, PharmD, Chairman of Purely Plant GmbH, underlines the importance of ensuring high and reproducible quality when it comes to medicinal cannabis.
series B equity financing, mile high

MHL Series B equity financing and global CPG partnerships

Here, we learn how Mile High Labs, a leading processor of hemp-derived cannabinoids, have raised Series B equity financing and are preparing for global CPG partnerships.
import of medical cannabis, drug

The import of medical cannabis: Germany and the Netherlands

Kathleen Denoodt continues to enlighten us on the subject of medical cannabis, particularly imports to Germany and the Netherlands.
drug testing

Stop drug testing and start impairment testing

A new public health app by DRUID® measures factors to give an overall score of impairment, evolving the classic idea of drug testing.
CBD novel food applications

The European Commission’s ‘pause’ on CBD novel food applications

Associate, David Hardstaff and Partner, John Binns at BCL Solicitors LLP, explain here how cannabis wonder child takes a knock in light of the European Commission’s ‘pause’ on CBD novel food applications mean for this booming industry.
chronic pain diseases, cannabinoids

Chronic pain diseases and medical cannabis

Janosch Kratz discusses the importance of medical cannabis for chronic pain diseases.
THC in CBD, EUMCA

EUMCA: Limit of 0.2% THC in CBD products should not change

Chair of the European Medicinal Cannabis Association (EUMCA) issues warning that raising limit for THC in CBD to 0.3% will risk patient safety.
medical cannabis

How are different types of medical cannabis working for different diseases?

Dr David Moorhouse, General Neurologist, discusses the way that different diseases respond to different types of medical cannabis.

Follow Open Access Government